Shravan Kannan

At ASDRP, I performed research on human epigenetic inhibitors, specifically DNA methyltransferases. I studied the impact of drugs like decitabine and RG108 on the cell viability of HCT116 colorectal cancer cells. I also presented this work at the American Chemical Society conference.